Desferrioxamine-related ocular toxicity: A case report.
Indian J Ophthalmol
;
2012 Jul-Aug; 60(4): 315-317
Artigo
em Inglês
| IMSEAR
| ID: sea-144860
ABSTRACT
A 29-year-old lady receiving repeated blood transfusions for β thalassemia since childhood, presented with rapidly deteriorating symptoms of night blindness and peripheral visual field loss. She was recently commenced on high-dose intravenous desferrioxamine for reducing the systemic iron overload. Clinical and investigative findings were consistent with desferrioxamine-related pigmentary retinopathy and optic neuropathy. Recovery was partial following cessation of desferrioxamine. This report highlights the ocular side-effects of desferrioxamine mesylate and the need to be vigilant in patients on high doses of desferrioxamine.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Doenças Retinianas
/
Transfusão de Sangue
/
Feminino
/
Humanos
/
Talassemia beta
/
Adulto
/
Desferroxamina
Idioma:
Inglês
Revista:
Indian J Ophthalmol
Ano de publicação:
2012
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS